Cargando…

Outcomes and costs of ureteroscopy, extracorporeal shockwave lithotripsy, and percutaneous nephrolithotomy for the treatment of urolithiasis: an analysis based on health insurance claims data in Germany

PURPOSE: Comparisons of ureteroscopy (URS), extracorporeal shockwave lithotripsy (SWL), and percutaneous nephrolithotomy (PCNL) for urolithiasis considering long-term health and economic outcomes based on claims data are rare. Our aim was to analyze URS, SWL, and PCNL regarding complications within...

Descripción completa

Detalles Bibliográficos
Autores principales: Schulz, Claudia, Becker, Benedikt, Netsch, Christopher, Herrmann, Thomas R. W., Gross, Andreas J., Westphal, Jens, Knoll, Thomas, König, Hans-Helmut
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8948106/
https://www.ncbi.nlm.nih.gov/pubmed/34910235
http://dx.doi.org/10.1007/s00345-021-03903-2
_version_ 1784674594501689344
author Schulz, Claudia
Becker, Benedikt
Netsch, Christopher
Herrmann, Thomas R. W.
Gross, Andreas J.
Westphal, Jens
Knoll, Thomas
König, Hans-Helmut
author_facet Schulz, Claudia
Becker, Benedikt
Netsch, Christopher
Herrmann, Thomas R. W.
Gross, Andreas J.
Westphal, Jens
Knoll, Thomas
König, Hans-Helmut
author_sort Schulz, Claudia
collection PubMed
description PURPOSE: Comparisons of ureteroscopy (URS), extracorporeal shockwave lithotripsy (SWL), and percutaneous nephrolithotomy (PCNL) for urolithiasis considering long-term health and economic outcomes based on claims data are rare. Our aim was to analyze URS, SWL, and PCNL regarding complications within 30 days, re-intervention, healthcare costs, and sick leave days within 12 months, and to investigate inpatient and outpatient SWL treatment as the latter was introduced in Germany in 2011. METHODS: This retrospective cohort study based on German health insurance claims data included 164,203 urolithiasis cases in 2008–2016. We investigated the number of complications within 30 days, as well as time to re-intervention, number of sick leave days and hospital and ambulatory health care costs within a 12-month follow-up period. We applied negative binomial, Cox proportional hazard, gamma and two-part models and adjusted for patient variables. RESULTS: Compared to URS cases, SWL and PCNL had fewer 30-day complications, time to re-intervention within 12 months was decreased for SWL and PCNL, SWL and PCNL were correlated with a higher number of sick leave days, and SWL and particularly PCNL were associated with higher costs. SWL outpatients had fewer complications, re-interventions and lower costs than inpatients. This study was limited by the available information in claims data. CONCLUSION: URS cases showed benefits in terms of fewer re-interventions, fewer sick leave days, and lower healthcare costs. Only regarding complications, SWL was superior. This emphasizes URS as the most frequent treatment choice. Furthermore, SWL outpatients showed less costs, fewer complications, and re-interventions than inpatients. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00345-021-03903-2.
format Online
Article
Text
id pubmed-8948106
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-89481062022-04-07 Outcomes and costs of ureteroscopy, extracorporeal shockwave lithotripsy, and percutaneous nephrolithotomy for the treatment of urolithiasis: an analysis based on health insurance claims data in Germany Schulz, Claudia Becker, Benedikt Netsch, Christopher Herrmann, Thomas R. W. Gross, Andreas J. Westphal, Jens Knoll, Thomas König, Hans-Helmut World J Urol Original Article PURPOSE: Comparisons of ureteroscopy (URS), extracorporeal shockwave lithotripsy (SWL), and percutaneous nephrolithotomy (PCNL) for urolithiasis considering long-term health and economic outcomes based on claims data are rare. Our aim was to analyze URS, SWL, and PCNL regarding complications within 30 days, re-intervention, healthcare costs, and sick leave days within 12 months, and to investigate inpatient and outpatient SWL treatment as the latter was introduced in Germany in 2011. METHODS: This retrospective cohort study based on German health insurance claims data included 164,203 urolithiasis cases in 2008–2016. We investigated the number of complications within 30 days, as well as time to re-intervention, number of sick leave days and hospital and ambulatory health care costs within a 12-month follow-up period. We applied negative binomial, Cox proportional hazard, gamma and two-part models and adjusted for patient variables. RESULTS: Compared to URS cases, SWL and PCNL had fewer 30-day complications, time to re-intervention within 12 months was decreased for SWL and PCNL, SWL and PCNL were correlated with a higher number of sick leave days, and SWL and particularly PCNL were associated with higher costs. SWL outpatients had fewer complications, re-interventions and lower costs than inpatients. This study was limited by the available information in claims data. CONCLUSION: URS cases showed benefits in terms of fewer re-interventions, fewer sick leave days, and lower healthcare costs. Only regarding complications, SWL was superior. This emphasizes URS as the most frequent treatment choice. Furthermore, SWL outpatients showed less costs, fewer complications, and re-interventions than inpatients. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00345-021-03903-2. Springer Berlin Heidelberg 2021-12-15 2022 /pmc/articles/PMC8948106/ /pubmed/34910235 http://dx.doi.org/10.1007/s00345-021-03903-2 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Original Article
Schulz, Claudia
Becker, Benedikt
Netsch, Christopher
Herrmann, Thomas R. W.
Gross, Andreas J.
Westphal, Jens
Knoll, Thomas
König, Hans-Helmut
Outcomes and costs of ureteroscopy, extracorporeal shockwave lithotripsy, and percutaneous nephrolithotomy for the treatment of urolithiasis: an analysis based on health insurance claims data in Germany
title Outcomes and costs of ureteroscopy, extracorporeal shockwave lithotripsy, and percutaneous nephrolithotomy for the treatment of urolithiasis: an analysis based on health insurance claims data in Germany
title_full Outcomes and costs of ureteroscopy, extracorporeal shockwave lithotripsy, and percutaneous nephrolithotomy for the treatment of urolithiasis: an analysis based on health insurance claims data in Germany
title_fullStr Outcomes and costs of ureteroscopy, extracorporeal shockwave lithotripsy, and percutaneous nephrolithotomy for the treatment of urolithiasis: an analysis based on health insurance claims data in Germany
title_full_unstemmed Outcomes and costs of ureteroscopy, extracorporeal shockwave lithotripsy, and percutaneous nephrolithotomy for the treatment of urolithiasis: an analysis based on health insurance claims data in Germany
title_short Outcomes and costs of ureteroscopy, extracorporeal shockwave lithotripsy, and percutaneous nephrolithotomy for the treatment of urolithiasis: an analysis based on health insurance claims data in Germany
title_sort outcomes and costs of ureteroscopy, extracorporeal shockwave lithotripsy, and percutaneous nephrolithotomy for the treatment of urolithiasis: an analysis based on health insurance claims data in germany
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8948106/
https://www.ncbi.nlm.nih.gov/pubmed/34910235
http://dx.doi.org/10.1007/s00345-021-03903-2
work_keys_str_mv AT schulzclaudia outcomesandcostsofureteroscopyextracorporealshockwavelithotripsyandpercutaneousnephrolithotomyforthetreatmentofurolithiasisananalysisbasedonhealthinsuranceclaimsdataingermany
AT beckerbenedikt outcomesandcostsofureteroscopyextracorporealshockwavelithotripsyandpercutaneousnephrolithotomyforthetreatmentofurolithiasisananalysisbasedonhealthinsuranceclaimsdataingermany
AT netschchristopher outcomesandcostsofureteroscopyextracorporealshockwavelithotripsyandpercutaneousnephrolithotomyforthetreatmentofurolithiasisananalysisbasedonhealthinsuranceclaimsdataingermany
AT herrmannthomasrw outcomesandcostsofureteroscopyextracorporealshockwavelithotripsyandpercutaneousnephrolithotomyforthetreatmentofurolithiasisananalysisbasedonhealthinsuranceclaimsdataingermany
AT grossandreasj outcomesandcostsofureteroscopyextracorporealshockwavelithotripsyandpercutaneousnephrolithotomyforthetreatmentofurolithiasisananalysisbasedonhealthinsuranceclaimsdataingermany
AT westphaljens outcomesandcostsofureteroscopyextracorporealshockwavelithotripsyandpercutaneousnephrolithotomyforthetreatmentofurolithiasisananalysisbasedonhealthinsuranceclaimsdataingermany
AT knollthomas outcomesandcostsofureteroscopyextracorporealshockwavelithotripsyandpercutaneousnephrolithotomyforthetreatmentofurolithiasisananalysisbasedonhealthinsuranceclaimsdataingermany
AT konighanshelmut outcomesandcostsofureteroscopyextracorporealshockwavelithotripsyandpercutaneousnephrolithotomyforthetreatmentofurolithiasisananalysisbasedonhealthinsuranceclaimsdataingermany